Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots ...

Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive ...

In the same year, it also created the Novartis Institutes for BioMedical Research (NIBR), which headquarters in the US. In 2003, Novartis acquired the worldwide adult medical nutrition business of ...

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...

On Monday, the U.S. District Court for the District of Massachusetts temporarily blocked the National Institutes of Health (NIH) from cutting research funding in 22 states. What Happened ...

The National Institutes of Health has announced plans to slash about $4 billion in funding for biomedical research — a move that could have an immediate impact on research at universities ...

In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

Zacks Research also issued estimates for Novartis’ Q4 2025 earnings at $2.08 EPS, Q3 2026 earnings at $2.39 EPS and Q4 2026 earnings at $2.24 EPS. Get Novartis alerts: ...

The National Institutes of Health has awarded the Alliance for Advancing Biomedical Research a potential 25-year, $89 billion recompete contract to manage and operate a federally funded research ...